DLA Piper has represented Lucas GC Limited in the transaction. Lucas GC Limited (Lucas) executed its initial public offering and listing on Nasdaq. It offered 1,500,000...
Lucas GC Limited’s US$6 Million Initial Public Offering
Haemonetics’ US$160 Million Acquisition of Attune Medical
DLA Piper represented Haemonetics Corporation in the transaction. Haemonetics Corporation (Haemonetics), a global medical technology company focused on delivering innovative medical solutions to drive better patient...
Voi’s Funding Round
DLA Piper advised Voi on the deal. Voi secured 255 million SEK in new capital from existing shareholders. Voi’s presence in over 100 cities across 12...
Deutsche Beteiligungs’ Share Buyback Program
DLA Piper has advised Deutsche Beteiligungs AG on the transaction. Deutsche Beteiligungs AG, a financial investor for medium-sized companies, announced the introduction of a share buyback program...
Fusion Antibodies’ GBP1.375 Million Shares Placing
DLA Piper advised Fusion Antibodies plc on the transaction. Fusion Antibodies plc announced its successful raising of GBP1.375 million (before expenses) through the placement of 34,375,000...
Emtec’s Acquisition of Folcode
Beccar Varela and Gibson Dunn & Crutcher advised Bridgenext, while DLA Piper Argentina advised Folcode on the deal. Folcode, a boutique digital engineering services company based...
Per Lindberg BidCo’s Public Takeover Offering
DLA Piper acted as advisor to the Board of Directors of Ranplan Group on the offering. Per Lindberg (CEO and principal owner of Ranplan Group), through...
Collins Aerospace’s Sale of its Holding in CTT Systems AB
DLA Piper assisted Collins Aerospace on the deal. Collins Aerospace completed the sale of approximately 1.1 million shares in CTT Systems AB (publ), a company listed...
Bunzl’s Acquisition of Pamark Business
DLA Piper advised Pamark Group on the deal. Pamark Group completed the sale of the entire share capital of Pamark Business to Bunzl Holding Nordic A/S, owned...
Iovance Biotherapeutics’ US$211 Million Common Stock Offering
DLA Piper advised Iovance Biotherapeutics, Latham & Watkins advised the underwriters on the transaction. Iovance Biotherapeutics, Inc. (Iovance), a biotechnology company focused on innovating, developing and...
Atrum Coal Limited’s AUD 5 Million Entitlement Offer
DLA Piper advised Atrum Coal Limited on the deal. Atrum Coal Limited (ASX: ATU) announced an underwritten accelerated non-renounceable entitlement offer to raise gross proceeds of...
Inspire Brands’ Acquisition of Vromo
DLA Piper advised Inspire Brands on the deal. Inspire Brands, Inc. (Inspire Brands), the second largest foodservice company in the United States, executed the acquisition of Vromo...